Stock in Foghorn Therapeutics Inc. was up about 14 percent Friday morning in its first day of trading on the Nasdaq exchange, after the Cambridge biotech startup raised $120 million in its initial public offering.
The biotech on Thursday said it would offer 7.5 million shares at $16 apiece, the midpoint of its expected range of $15 to $17. The stock is trading under the ticker FHTX.
